Ding M, Coward RJ, Jeansson M, Kim W, Quaggin SE. Regulation of hypoxia-inducible factor 2-␣ is essential for integrity of the glomerular barrier. Am J Physiol Renal Physiol 304: F120 -F126, 2013. First published October 10, 2012 doi:10.1152/ajprenal.00416.2012.-Deletion of the von Hippel-Lindau tumor suppressor (Vhl) gene from renal podocytes of mice (podVhl KO) leads to rapidly progressive glomerulonephritis (RPGN), a clinical syndrome characterized by rapid loss of renal function and crescents on renal biopsy. Genomic profiling of glomeruli isolated from podVhl knockout (KO) mice and from patients with RPGN identified a fingerprint of genes regulated by hypoxia-inducible factors (HIF), important substrates of the product of the VHL gene. Here, we show that stabilization of Hifs in podocytes is both required and sufficient for the glomerular phenotype observed in podVhl KO mice. Genetic deletion of the obligate dimerization partner Arnt/Hif1b that is essential for Hif transcriptional function rescues the phenotype. Conversely, stabilization of HIF2A alone in podocytes results in crescentic glomerular disease. Together, our results show that the Hif pathway and Hif2a in particular are key players in maintenance of the glomerular barrier.
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS (RPGN) is a devastating clinical syndrome characterized by death or progression to end-stage renal failure within weeks to months if left untreated. Histologically, crescentic transformation is found on renal biopsy. Classification is based on the presence of circulating antibodies, immune complex deposition, or the absence of immune complexes; the latter condition is known as pauciimmune RPGN and the majority of these patients have antibodies to anti-neutrophil cytoplasmic antibodies (ANCA). However, in a portion of these cases, no antibodies are detected (4) . Pathogenesis of this disorder is incompletely known and may occur as a focal or global process in affected glomeruli.
In a previous study, we showed that disruption of the von Hippel-Lindau tumor suppressor (Vhl) gene in podocytes results in a clinical syndrome in mice similar to RPGN. Using the Cre-loxP system, we deleted the Vhl gene specifically from podocytes. Glomeruli developed normally but at 2 and a half wk of age, the mice developed hematuria, proteinuria, and succumbed to end-stage renal failure by 7 wk of age (3) . These results showed that an intrinsic defect in podocytes is sufficient to initiate the pathologic features of RPGN in a mouse model and further identified upregulation of hypoxia-inducible factor (Hif) target genes as a potential mechanism. Intriguingly, we identified a fingerprint of HIF target genes in glomeruli from patients with RPGN that was not observed in other glomerular diseases (3) .
The product of the von Hippel-Lindau gene is the substrate recognition component of an E3 ubiquitin ligase; it binds proteins and targets them for degradation in the proteasome (15, 16, 18) . HIF1A and HIF2A are the best-known substrates for the product of the VHL gene (pVHL). In normoxic conditions, specific proline residues on HIF1A and HIF2A are hydroxylated; this allows pVHL to bind them. Conversely, under hypoxic conditions, pVHL cannot bind and the HIFA subunits are stabilized. A common subunit known as HIF1B or ARNT dimerizes with HIF1A or HIF2A, resulting in a complex that activates transcription of a number of downstream target genes such as vascular endothelial growth factor A (VEGFA), CXCR4, and its ligand SDF1/CXCL12 that are involved in angiogenesis, development, and oncogenesis. In addition to HIFA subunits, the aryl hydrocarbon receptor (AHR) also dimerizes with ARNT, in response to environmental toxins or ligands. Upon translocation to the nucleus and dimerization, the ARNT/AHR heterocomplex is responsible for regulation of a number of additional transcriptional targets including genes involved in the metabolism of toxic substances (13) .
Based on our previous results, we hypothesized that stabilization of Hif ␣ subunits, either one or both, is required and sufficient to cause glomerular disease and is the major pathway involved in the dramatic phenotypes observed in the podVhl knockout (KO) mice. However, alternate substrates for pVHL exist leaving open the possibility that non-HIF pathways are also important (21, 23) . To test our hypothesis, we first deleted the common Hif subunit Hif1b from podVhl KO mice and show that the phenotype is completely rescued. Next, we generated gain-of-function podocyte-specific HIF mutant mice and show that upregulation of HIF2A alone in podocytes is sufficient to cause crescentic glomerular disease and a clinical course indistinguishable from podVhl KO mice. Finally, to determine whether postnatal deletion of Vhl from podocytes is sufficient to cause an RPGN phenotype similar to embryonic deletion, we generated an inducible podocyte KO model for Vhl. When induced at postnatal day 0, these mice also develop crescentic glomerular disease and die before 2 mo of age. Together, our results demonstrate the importance of the VhlHif pathway and its regulation in glomerular barrier function.
METHODS
Generation of transgenic mice. All animal experimentation was conducted in accordance with the Canadian Guide for the Care and (22) . To generate mice with podocyte-selective deletion of Arnt, Nphs2-Cre mice were bred to Arnt flox/flox homozygotes. Genotype was confirmed by PCR analysis as outlined below. To generate mice carrying podocyte-selective deletions of both Vhl and Arnt, homozygous Arnt flox/flox mice were bred with Vhl flox/ϩ, Nphs2-Cre mice. After several breedings, mice carrying all five transgenes were obtained (Vhl flox/flox; Arnt flox/flox; Nphs2-Cre). Genotypes were confirmed by PCR. The pod-rtTA/tetO-Cre bitransgenic mouse line is described in Ref. 5 ; it was bred to mice homozygous for the Vhl flox allele. Mice carrying all four transgenes (podrtTA/tetO-Cre, Vhl flox/flox) were generated and induced with doxycyline (2 mg/ml) in the drinking water at postnatal day 0. Induction details are described in Ref. 5 .
Two transgenic mouse lines expressing either a HIF1A or a HIF2A variant cDNA (12) , under a floxed stop codon driven by the Rosa26 promoter, were kindly provided by Dr. William G Kaelin Jr.'s laboratory at Harvard Medical School and Dr. Billy Kim in the University of North Carolina. An HA tag is expressed upon translation of the transgene. The HIFA transgenic mice were bred with the Nphs2-Cre mouse line. Upon Cre-mediated excision of the stop codon, transgenic mice that express stabilized versions of HIF1A or HIF2A selectively in their podocytes were obtained (11) .
Given the large number of transgenes and complex breeding strategies, the genetic background strain for all mice used in this study was mixed. Littermates were used for all comparisons such as glomerular pathology, urine protein:creatinine measurements, etc.
Urinalysis. Spot urine was collected from mice from 2 wk of age up until 11 mo depending on genotype and life span. Urine dipsticks (Chemstrip 5L; Roche Diagnostics) were used to detect the presence or absence of protein and red blood cells in the urine according to the manufacturer's instructions.
In addition, urine was passively collected from specified mice at 2, 3, 4, 5, 6, and 8 wk to measure protein:creatinine ratios. Protein was measured according to the manufacturer's instructions (Protein Assay, Bio-Rad, Mississauga, ON, Canada) and creatinine was measured using the Jaffe method (KGE005, R&D Systems).
Genotype analysis. Genomic DNA from tails of 3-wk-old transgenic mice was isolated and used for genotypic analysis as described (6) . The Nphs2-Cre transgene (6), Vhl flox allele (3), and Arnt flox (22) were detected by PCR as described.
The HIF1A and HIF2A transgenes were detected by Hif1a, Hif2a, and Rosa26 PCR as described (11) . Primer sequences are listed below: HIF1A forward: 5=-GAAAGCGCAAGTCCTCAAAG-3=, HIF1A reverse: 5=-TGGGTAGGAGATGGAGATGC-3=; HIF2A forward: 5=-GAAATCAGCTTCCTGCGAAC-3=, HIF2A reverse: 5=-TCATGAA-GAAGTCCCGCTCT-3=.
Histologic analysis. Transgenic mouse kidneys were dissected for histologic analysis, fixed in 10% formalin in PBS, and embedded in paraffin. Sections (4-m thick) were cut and stained with Periodic Acid-Schiff (PAS) or hematoxylin and eosin (H&E), examined, and photographed with a DC 200 Leica camera and Leica DMLB microscope (Leica Microsystems).
Glomerular isolation. The kidneys from mice were perfused with PBS followed by perfusion with 15 ml of PBS containing 1.25% Fe3O4 via the left ventricle (1). Kidneys were decapsulated and pressed through a 106-m metal sieve with a flatted plastic pestle, washed with a jet of PBS, and collected in a siliconized plastic beaker. The suspension was transferred to siliconized conical 50-ml centrifuge tubes, which were placed against a magnet for 30 s before the supernatant was removed. Next, the tube was removed from the magnetic field, the inner wall was washed with PBS, and the resuspended glomeruli were washed by repeating this procedure three times. After the last wash, the resuspended glomeruli were pelleted by centrifugation (1 min, 1,200 g), and the pellet was put into RLT buffer from a QIAGEN RNeasy RNA isolation kit.
Western blot analysis. Glomerular extracts were obtained from mutant and control animals at 4 wk of age and the extract was then lysed with modified RIPA buffer as previously described (20) . After being blotted, protein was detected using primary antibodies including mouse anti-HA 1:20,000 (gift from Dr. Tony Pawson, University of Toronto) and rabbit anti-podocin 1:1,000 (Sigma). Species-specific HRP secondary antibodies (Santa Cruz Biotechnology) were applied for 1 h at a concentration of 1:10,000 for anti-HA and 1:15,000 for anti-podocin.
Statistics. Data are expressed as means Ϯ SE. Statistical analysis was performed using two-tailed Student's t-test or ANOVA when appropriate to analyze statistically significant differences between groups. Log-rank analysis was used to compare differences in survival (Kaplan Meier Survival curve). A P value of Ͻ0.05 is considered to be statistically significant. bred to mice carrying the podocin-Cre transgene (Fig. 1A) . Mice carrying all three transgenes were identified by PCR (not shown). PodArnt KO mice were born in the expected Mendelian frequency and did not develop any proteinuria or glomerular phenotype before 11 mo of age. At 11 mo, mild proteinuria was detected by dipstick analysis (1ϩ) and mild mesangial expansion was observed on light microscopy (Fig. 1B) . However, the mice appeared active and healthy excluding a major role for Arnt in development or function of podocytes. This allowed us to breed the mice onto the podVhl KO background.
RESULTS

Podocyte-selective deletion of
Podocyte-selective deletion of Arnt from podVhl KO mice rescues the RPGN phenotype. To determine whether Hif stabilization is required for the RPGN phenotype, we bred the podVhl KO mice to podArnt KO mice ( Fig. 2A) . Loss of Hif1b prevents Hifa subunits from binding to their target genes and initiating transcription. Mice carrying all five transgenes survived until 8 mo of age when they were killed. Importantly, survival was dramatically improved with no deaths in podArnt /podVhl double mutant mice (Fig. 2B ). Mice carrying a single Arnt floxed allele and two Vhl floxed alleles developed disease at 7 wk, similar to podVhl KO alone (Fig. 2C and data not shown). At 8 mo of age, occasional glomeruli (Ͻ5%) exhibited crescentic transformation (data not shown), suggesting incomplete excision of Arnt in these few glomeruli or a non-HIFmediated mechanism of disease.
HIF transgenic mice develop glomerular disease. The Arnt rescue experiments confirm a requirement for Hif stabilization in the pathogenesis of glomerular disease in this model. To determine whether HIF stabilization is sufficient and whether there is a specific role for HIF1A or HIF2A, we generated gain-of-function mutant mice (Fig. 3) . Mice carrying mutant stabilized versions of HIF1A or HIF2A in podocytes were generated. In the mutant HIFA subunits, the prolines at positions P402A and P531A in HIF1A and P405A and P531A in HIF2A are mutated to alanine that prevents hydroxylation and permits escape from pVhl recognition (Fig. 3A) . The transgenes are both targeted to the ubiquitous Rosa locus that expresses in renal podocytes (not shown). Upon breeding to Nphs2-Cre mice, excision of a floxed STOP codon permits transcription and translation of the HIF transgene (Fig. 3B) . To confirm stabilization of the HIF proteins in these mice, we isolated RNA and protein from glomeruli and performed realtime PCR and Western blot analysis. While HIF1A and HIF2A transcripts are increased in glomeruli from respective HIF1A and HIF2A transgenic mice (not shown), the level of protein stabilization of HIF1A was much lower than HIF2A when controlled for a podocyte-specific protein (podocin; Fig. 3B ). HIF1A and HIF2A were detected by antibodies to the HA tag. This is similar to results obtained when these transgenes are selectively expressed in the liver (11) . Although the reason for low-protein expression is unclear, it is thought to result from a VHL-independent proteasomal degradation pathway that exists for HIF1A (11) .
HIF2A but not HIF1A mice develop glomerular disease. Mice carrying a single HIF2A transgene (i.e., mice that are heterozygotes for the knock-in allele) develop proteinuria and mild glomerular disease with occasional crescents by 5 mo of age (Fig. 4A) , while mice carrying two copies develop more severe glomerular disease by 5 wk of age and succumb by 8 wk of age. Proteinuria increases progressively from ϳ20 mg/mg (protein:creatinine ratio) at 3 wk to 130 mg/mg at time of death (8 wk; Fig. 4B ). Glomerular histology of HIF2A homozygotes exhibits many similarities to podVhl KO mice (Fig. 4A) . In contrast, HIF1A heterozygous and homozygous mice do not develop clinically significant glomerular disease as demonstrated by protein: creatinine ratios and histology (Fig. 4C and data not shown) . Given the lower level of HIF1A expression and difference in severity of phenotypes in the HIF2A heterozygous vs. homozygous mice, it is likely that level of HIF expression is important in development of the phenotype (Fig. 4D) .
Postnatal deletion of Vhl from podocytes results in RPGN.
Additional groups have used the Cre-loxP system to delete the Vhl gene from podocytes (2). Although they observe increased susceptibility to glomerular injury, they did not observe an RPGN phenotype. In the absence of direct comparisons, it is difficult to know why the phenotypes were different, although several possibilities exist that include mouse strain differences, specific effects of the Cre line, or differences in degree of excision of the gene of interest. In the latter case, it is important to note that reporter genes are only surrogate markers for excision efficiency and can vary from locus to locus, or depend on specific effects of the Cre line (i.e., our Nphs2-Cre line may have modified the phenotype in some way). To rule out the latter possibility, we utilized an alternative, inducible postnatal rtTA-tetO-Cre bitransgenic system (5). Following doxycycline induction at postnatal day 0, mice carrying all four transgenes (pod-rtTA/tetO-Cre/Vhlflox/flox) developed a phenotype indistinguishable from podVhl KO mice, suggesting that pVhl is important in postnatal as well as embryonic podocyte stages (Fig. 5) . Furthermore, the data confirm a robust, reproducible phenotype in podocytes upon deletion of the Vhl gene using two independent Cre deletor strategies on a mixed genetic background strain.
DISCUSSION
Using a series of genetic models, we showed that regulation of Hif's is critical to maintain integrity of the glomerular barrier. Deletion of the Vhl gene from podocytes results in stabilization of Hif1a and Hif2a subunits. Although Hifa subunits are stabilized in developing podocytes of these mice, problems do not appear until the major phase of glomerular development is complete, suggesting that hypoxia-inducible factors are not detrimental for podocytes before maturation of the glomerulus. Expression of Hifa subunits in developing podocytes of wild-type mice suggests that they are functionally important during this stage (7) . However, deletion of Hif's from developing podocytes is needed to confirm or refute this model. In fact, absence of a phenotype in podArnt KO mice reported here suggests that Hifs may be dispensable following the capillary loop stage of glomerular development.
By 3 wk of age, profound changes in glomerular structure occur in podVhl KO mice; podocytes begin to proliferate, and the endothelium is activated as shown by upregulation of genes such as tumor necrosis factor receptor (Tnfr), intracellular adhesion molecule (Icam), and selectins and mice succumb to a syndrome that resembles renal-restricted pauci-immune RPGN (3). We hypothesized that stabilization of Hifs in podocytes of these mice was a key factor in generation of the phenotype. Genomic profiling from glomeruli of podVhl KO mice and from patients with RPGN confirmed the presence of a HIF fingerprint with upregulation of many known HIF target genes such as transforming growth factor alpha (Tgfa), Vegf, Cxcr4, Sdf1/Cxcr12, etc. (3). However, definitive proof required additional genetic studies as described here. The complete rescue of phenotype in Vhl-Arnt double mutant mice confirms that Hif stabilization is absolutely required for glomerular disease in this model. Deletion of Hif1b prevents the formation of active Hifa transcriptional complexes, inhibiting activation of downstream targets. Interestingly, developmental deletion of Hif1b from podocytes did not result in any clinical renal disease in these mice before the age of 11 mo, suggesting that Hifs may not be required for glomerular development from the capillary loop stage onwards. Because Arnt is also an obligate dimerization partner for the AHR, our results also suggest that Ahr is dispensable in the podocyte. In contrast, embryonic loss of Ahr in constitutive knockout mice results in vascular defects in various organs including the kidney (13) .
Importantly, stabilization of HIF2A results in a phenotype very similar to podVhl KO mice and suggests that it might play a key role in the disease process. Rapid development of severe glomerular disease in homozygotes compared with a much slower and milder disease in heterozygotes suggests that the "dose" or level of expression of HIF2A is also important. As expression of HIF1A protein was much lower in our transgenic mice, we cannot exclude a role for HIF1A in disease yet, although the fact that HIF2A overexpressors develop disease very similar to podVhl KO mice suggests that this may be the key factor involved. In a variety of physiologic and disease settings including renal cell carcinoma, HIF2A also appears to play a unique and perhaps dominant role (8, 9, 19) . It is interesting to speculate that HIF2A may be particularly important in renal physiology.
Mouse models are a precise and robust way to manipulate gene pathways "to the extreme." How might these results translate to patients with glomerular disease? Although glomeruli and podocytes are not hypoxic under normal circumstances, many other factors known to be involved in renal disease can stabilize HIFs including angiotensin II, nitric oxide, TNF-␣, glucose, the phosphoinositide 3-kinase/ Akt-1/mammalian target of rapamycin pathway, and a variety of growth factors such as epidermal growth factor and insulin-like growth factors (24, 25) . Although these pathways have not all been shown to regulate HIFs in glomerular disease yet, studies have demonstrated changes in glomerular Hif expression in diabetic rats and in cultured podocytes and mesangial cells exposed to glucose (10, 14) . Pharmacologic agents such as prolyl hydroxylase inhibitors, which stabilize HIFa subunits, are under development for treatment of chronic anemia and vascular disease. It is plausible that such agents might accelerate inflammatory glomerular injury and it will be important to follow patients carefully.
Although our studies focused on the role of HIFs in glomerular pathology, it is well-known that the effects of HIF stabilization extend to other renal cell types, even in noncancerous settings. While HIF stabilization and hypoxic preconditioning protect the kidney from acute kidney injury, more prolonged or severe hypoxia appears to promote injury [reviewed in Nangaku et al. (17) ], underscoring the importance of "dosage." In the setting of fibrosis, investigators showed that angiotensin II results in upregulation of Hif1a in cultured medullary rat fibroblasts, leading to a profibrotic phenotype, which is rescued by Hif1a knockdown or transfer of a transgene encoding the prolyl hydroxylase (23) .
In summary, our data demonstrate an important role for the VHL-HIF pathway in maintaining glomerular barrier integrity. Demonstration of dosage sensitivity in our transgenic lines suggests that HIFs and their target genes are interesting candidates to consider as biomarkers or therapeutic targets in glomerular disease.
